A. Dellsén

发表

Discovery of novel class 1 phosphatidylinositide 3-kinases (PI3K) fragment inhibitors through structure-based virtual screening.

F. Giordanetto, B. Kull, A. Dellsén, 2011, Bioorganic & medicinal chemistry letters.

Exploring Binding Mechanisms in Nuclear Hormone Receptors by Monte Carlo and X-ray-derived Motions.

Victor Guallar, Christian Tyrchan, Christoph Grebner, 2017, Biophysical journal.

Macrocyclic Modalities Combining Peptide Epitopes and Natural Product Fragments

Stéphanie M. Guéret, A. Plowright, H. Waldmann, 2020, Journal of the American Chemical Society.

Structure‐Based Drug Design of Mineralocorticoid Receptor Antagonists to Explore Oxosteroid Receptor Selectivity

Yafeng Xue, A. Gunnarsson, A. Hogner, 2017, ChemMedChem.

Discovery of retinoic acid receptor agonists as proliferators of cardiac progenitor cells through a phenotypic screening approach

A. Plowright, I. Barrett, S. Martinsson, 2019, Stem cells translational medicine.

Late-Stage Functionalization with Cysteine Staples Generates Potent and Selective Melanocortin Receptor-1 Agonists.

Andrew M. White, A. Plowright, D. Craik, 2022, Journal of medicinal chemistry.

Human 4-hydroxyphenylpyruvate dioxygenase. Primary structure and chromosomal localization of the gene.

A. Dellsén, G. Stenman, S. Lindstedt, 1993, European journal of biochemistry.

Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis

A Jawaid, E M Brown, L R Cardon, 2008, The Pharmacogenomics Journal.

Discovery and Early Clinical Development of an Inhibitor of 5-Lipoxygenase Activating Protein (AZD5718) for Treatment of Coronary Artery Disease.

A. Plowright, J. Ulander, Malin Lemurell, 2019, Journal of medicinal chemistry.

RAR-related orphan receptor A isoform 1 (RORa1) is disrupted by a balanced translocation t(4;15)(q22.3;q21.3) associated with severe obesity

J. Ludvigsson, B. Åsling, G. Annéren, 2005, European Journal of Human Genetics.

Development of Novel Melanocortin Receptor Agonists Based on the Cyclic Peptide Framework of Sunflower Trypsin Inhibitor-1.

Philipp M. Cromm, A. Plowright, D. Craik, 2018, Journal of medicinal chemistry.

Melanocortin 1 Receptor Agonists Based on a Bivalent, Bicyclic Peptide Framework.

Andrew M. White, A. Plowright, D. Craik, 2021, Journal of medicinal chemistry.